Journal
PSYCHO-ONCOLOGY
Volume 26, Issue 12, Pages 2294-2299Publisher
WILEY
DOI: 10.1002/pon.4362
Keywords
cancer; depression; medication adherence; oncology; physical functioning
Funding
- National Cancer Institute [CA97916-01]
Ask authors/readers for more resources
ObjectiveDespite the efficacy of clinical treatments (eg, adjuvant hormonal therapy) for breast cancer survivors (BCS), nonadherence rates remain high, increasing the risk of recurrence and mortality. The current study tested a theoretical model of medical nonadherence that proposes depression to be the most proximal predictor of medical nonadherence among BCS. MethodsBreast cancer survivors were recruited from radiation clinics in Missouri. Survey data were collected 12months after the end of primary treatment. The sample size included 133 BCS. ResultsFindings show substantial support for the model, demonstrating that depression mediated the relation between physical symptoms, cognitive symptoms, social support, and adherence to medication. This finding was replicated with a measure of mood disturbance. ConclusionsThese findings support the prediction that medication nonadherence among BCS multiply determined process and have compelling implications for healthcare providers and interventions designed to increase medication adherence among BCS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available